Amgen Inc. AMGN and GSK plc GSK are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set ...
President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut the costs ...
The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the pr | ...
Amgen (AMGN) and GSK (GSK) are said to join TrumpRx, a newly launched government-run platform selling pharmaceutical products at lower cash prices. Read more here.
GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...
GSK on Wednesday agreed to pay $950 million in cash for Canadian biopharmaceutical company 35Pharma Inc, which is developing ...
Under the terms of the agreement, Alfasigma is expected to acquire worldwide exclusive rights to develop, manufacture and commercialize linerixibat, while GSK will receive an upfront payment of $300 ...
Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
If you are wondering whether GSK is still attractively priced after its recent run, you are not alone and this article is for ...
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK ...
March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for ...
With its significant population, skilled talent, and a government deeply committed to health, the country presents a unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results